Japanese
English
- 有料閲覧
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
要旨●大腸癌は,前癌病変である腺腫や早期癌を内視鏡的に早期発見し,切除・治療することで,大腸癌罹患率のみならず,死亡率まで減少することが証明されている.ADRがPCCRCの発生頻度と逆相関するため,AIによる見逃しのない内視鏡検査と質的診断の補助が望まれる.現在国内においてEndoBRAIN®シリーズ,CAD EYETM,WISE VISIONと3種類のAIが薬事承認され,AIによる大腸腫瘍性病変のdetection(病変発見)からcharacterization(質的診断)まで可能な時代となっている.
Early detection, resection, and treatment of precancerous adenomas and early-stage cancers have been proven to reduce not only the morbidity but also the mortality associated with CRC(colorectal cancer). Because of the inverse correlation with the incidence of post-colonoscopy CRC, it is desirable to use AI(artificial intelligence)to aid in endoscopy without missing anything. At present, three types of AI, i.e., ENDOBRAIN, CAD-EYE, and WISE-VISION, have been approved by pharmaceutical authorities in Japan and are capable of detecting colorectal tumors and assisting in their characterization.
Copyright © 2021, Igaku-Shoin Ltd. All rights reserved.